Evaluating usefulness of ING1 expression in stroma as a prognostic biomarker in breast cancer.

被引：0
|
作者：
Nabbi, Arash
Thakur, Satbir
Klimowicz, Alexander C.
Riabowol, Karl
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Univ Calgary, Tom Baker Canc Ctr, Dept Oncol, Calgary, AB, Canada
[3] Univ Calgary, Dept Pathol, Tom Baker Canc Ctr, Calgary, AB, Canada
[4] Univ Calgary, Dept Lab Med, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e11543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11543
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Identification of URST1 as a prognostic biomarker and therapeutic target for lung cancer.
    Takano, Atsushi
    Miyagi, Yohei
    Daigo, Yataro
    CANCER RESEARCH, 2021, 81 (13)
  • [42] SRC-1 Expression Is a Prognostic Factor of Breast Cancer-Specific and Disease-Free Survival in Inflammatory Breast Cancer.
    Arias-Pulido, H.
    Ahmed, R. D.
    Chaher, N.
    Vargas, J.
    Joste, N.
    Lomo, L.
    Qualls, C.
    Azziez, S.
    Terki, N.
    Bouzid, K.
    Prossnitz, E.
    Royce, M.
    CANCER RESEARCH, 2011, 71
  • [43] Cytokines as a prognostic biomarker of overall survival in pancreatic cancer.
    Tan, Harold Nathan Choa
    Nona Velasco, Rogelio
    San Juan, Michael Ducusin
    Cornelio, Gerardo H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Wnt5a Is a Prognostic Biomarker in Estrogen Receptor-Positive Premenopausal Breast Cancer.
    Sand-Dejmek, J. T.
    Ehrnstrom, R.
    Andersson, T.
    Ryden, L.
    CANCER RESEARCH, 2011, 71
  • [45] Prognostic role of androgen receptor expression in triple-negative breast cancer.
    Wang, Yanru
    Yang, Fang
    Wang, Yucai
    Zhong, Fengming
    Guan, Xiaoxiang
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Prognostic significance of tartrate-resistant acid phosphatase expression in breast cancer.
    Dai, Ming-Shen
    Lo, Hao-Chan
    Chen, Li-Jia
    Tseng, Shun-Fu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Osteopontin expression is an independent prognostic indicator in lymph node negative breast cancer.
    OMalley, FP
    Harris, JF
    Doig, GS
    Kerkvliet, N
    Saad, Z
    Bautista, D
    Tonkin, K
    Chambers, AF
    LABORATORY INVESTIGATION, 1996, 74 (01) : 109 - 109
  • [48] ING1 inhibits Twist1 expression to block EMT and is antagonized by the HDAC inhibitor vorinostat
    Yang, Yang
    Ma, Biao
    Djamshidi, Mahbod
    Zhang, Qingrun
    Sarkar, Anusi
    Chanda, Ayan
    Tran, Uyen
    Soh, Jung
    Sandall, Christina
    Chen, Huey-Miin
    MacDonald, Justin A.
    Bonni, Shirin
    Sensen, Christoph W.
    Zheng, Jianhua
    Riabowol, Karl
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2023, 102 (03)
  • [49] Prognostic relevance of partial hormone receptor expression in stage I breast cancer.
    Zwenger, Ariel
    Leone, Julieta
    Iturbe, Julian
    Perez Verdera, Palmira
    Pablo Leone, Jose
    Amadeo Leone, Bernardo
    Teodoro Vallejo, Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Prognostic significance of topoisomerase II alpha (Topo II) expression in breast cancer.
    Depowski, PL
    Rosenthal, SI
    Brien, TP
    Stylos, S
    Johnson, RL
    Ross, JS
    LABORATORY INVESTIGATION, 1999, 79 (01) : 19A - 19A
12345